NDC properties for "tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule" (RxCUI 198252)
About this data
The tables show NDC propoerties for tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule with the RxCUI 198252
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule (RxCUI 198252)
ANDA | ANDA060704 |
---|---|
ANDA | ANDA061837 |
ANDA | ANDA062752 |
ANDA | ANDA210662 |
ANDA | ANDA210674 |
ANDA | ANDA212635 |
MMSL_CODE | BD3025 |
MMSL_CODE | CD3025 |
NDA | NDA050278 |
RxCUI | 198252 |
SNOMEDCT | 375874002 |
SPL_SET_ID | 00acf413-c5d2-4a54-9d0d-56266cbc9edc |
SPL_SET_ID | 0c809fa5-c630-4bf1-a0fc-5ee875008807 |
SPL_SET_ID | 13a23307-61e4-4094-9132-68e38d200d18 |
SPL_SET_ID | 22208459-3e6f-46a7-9f7f-f2c254a38132 |
SPL_SET_ID | 2854d3b7-f874-4c67-8014-adda9639f515 |
SPL_SET_ID | 2c9208db-5f4f-4382-854f-6786b1e458db |
SPL_SET_ID | 32a409a0-fea6-411a-8218-c1c7df46d664 |
SPL_SET_ID | 3ce3e8dc-7fbd-4f8d-a65f-092e1ef21725 |
SPL_SET_ID | 5419f5dd-bf20-4eea-982d-33511a022c38 |
SPL_SET_ID | 54d1720d-edfc-4eb4-8388-f61bd5971336 |
SPL_SET_ID | aa30113f-ab58-4f41-82c1-2fcb540d4a82 |
SPL_SET_ID | ae29aa18-6efb-47c9-bbd7-cbe8af1b7f38 |
SPL_SET_ID | b45cee2a-8d11-4fda-b8f8-e1f71abf87c6 |
SPL_SET_ID | b504e612-5aef-47fa-8f7b-dfb754011b9f |
SPL_SET_ID | d07410b3-37e6-4382-97de-0c2676bc1103 |
SPL_SET_ID | eaa5b1bd-0927-46e4-b941-32fcc492d258 |
SPL_SET_ID | eb651905-007d-4a56-b010-db4a4f7c405d |
SPL_SET_ID | edf54a38-41a7-42ec-a05f-46ab20cb6fc3 |
SPL_SET_ID | fb338af1-2b1b-413f-9653-10f318dbc4b3 |
VUID | 4001910 |
Prescribable Synonym | tetracycline HCl 500 MG Oral Capsule |
RXNAV_STR | tetracycline hydrochloride 500 MG Oral Capsule |
RxNorm Name | tetracycline hydrochloride 500 MG Oral Capsule |
RxNorm Synonym | tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule |
RxNorm Synonym | tetracycline HCl 500 MG Oral Capsule |
Related queries | Interactions (for RxCUI 198252) |
NDC Properties
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
NDC 9 | 60219-1523 |
---|---|
NDC 10 | 60219-1523-1 |
NDC Item | 60219152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 758551 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-08-10 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-01 |
NDC Item | 62135026601 |
Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-05 |
NDC Item | 62135026605 |
Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-20 |
NDC Item | 62135026620 |
Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
NDC 9 | 62135-266 |
---|---|
NDC 10 | 62135-266-60 |
NDC Item | 62135026660 |
Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
ANDA | ANDA062752 |
COLORTEXT | orange,yellow |
Color | C48331;C48330 __ |
FDA SPL set id | 719885 |
Imprint code | 5266 |
Labeler | Chartwell RX, LLC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 1988-08-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
NDC 9 | 64380-891 |
---|---|
NDC 10 | 64380-891-06 |
NDC Item | 64380089106 |
Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
ANDA | ANDA212635 |
COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
Color | C48333;C48330 __ |
FDA SPL set id | 706992 |
Imprint code | TK;02 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-14 |
NDC Item | 66267020114 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-20 |
NDC Item | 66267020120 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-28 |
NDC Item | 66267020128 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
NDC 9 | 66267-201 |
---|---|
NDC 10 | 66267-201-40 |
NDC Item | 66267020140 |
Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
NDC 9 | 67405-661 |
---|---|
NDC 10 | 67405-661-10 |
NDC Item | 67405066110 |
Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE,YELLOW |
Color | C48331;C48330 __ |
FDA SPL set id | 378027 |
Imprint code | 5266 |
Labeler | Harris Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-01-31 |
Marketing effective time low | 1988-08-12 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
NDC 9 | 69238-1523 |
---|---|
NDC 10 | 69238-1523-1 |
NDC Item | 69238152301 |
Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
ANDA | ANDA210674 |
COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
Color | C48333;C48330 __ |
FDA SPL set id | 759174 |
Imprint code | AMNEAL;1523 |
Labeler | Amneal Pharmaceuticals NY LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-09-21 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-1 |
NDC Item | 71335214101 |
Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-2 |
NDC Item | 71335214102 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-3 |
NDC Item | 71335214103 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-4 |
NDC Item | 71335214104 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-5 |
NDC Item | 71335214105 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-6 |
NDC Item | 71335214106 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-7 |
NDC Item | 71335214107 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
NDC 9 | 71335-2141 |
---|---|
NDC 10 | 71335-2141-8 |
NDC Item | 71335214108 |
Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 781939 |
Imprint code | B907 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-1 |
NDC Item | 71335242701 |
Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-2 |
NDC Item | 71335242702 |
Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-3 |
NDC Item | 71335242703 |
Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-4 |
NDC Item | 71335242704 |
Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-5 |
NDC Item | 71335242705 |
Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-6 |
NDC Item | 71335242706 |
Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-7 |
NDC Item | 71335242707 |
Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
NDC 9 | 71335-2427 |
---|---|
NDC 10 | 71335-2427-8 |
NDC Item | 71335242708 |
Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 795541 |
Imprint code | 5266 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
NDC 9 | 0591-2475 |
---|---|
NDC 10 | 0591-2475-01 |
NDC Item | 00591247501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
ANDA | ANDA061837 |
COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48323;C48330 __ |
FDA SPL set id | 558144 |
Imprint code | WPI;2235 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-08-15 |
Marketing status | DROPPED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
NDC 9 | 10544-590 |
---|---|
NDC 10 | 10544-590-28 |
NDC Item | 10544059028 |
Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
ANDA | ANDA060704 |
COLORTEXT | black,yellow |
Color | C48323;C48330 __ |
FDA SPL set id | 17532 |
Imprint code | 2407 |
Labeler | Blenheim Pharmacal, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-03 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
NDC 9 | 23155-018 |
---|---|
NDC 10 | 23155-018-01 |
NDC Item | 23155001801 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
COLORTEXT | YELLOW(body),BLUE(cap) |
Color | C48330;C48333 __ |
FDA SPL set id | 524549 |
Imprint code | HP;18 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2024-09-15 |
Marketing status | COMPLETED |
NDA | NDA050278 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
NDC 9 | 23155-767 |
---|---|
NDC 10 | 23155-767-01 |
NDC Item | 23155076701 |
Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
ANDA | ANDA062752 |
COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 717683 |
Imprint code | 5266 |
Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2020-04-01 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
NDC 9 | 47781-509 |
---|---|
NDC 10 | 47781-509-01 |
NDC Item | 47781050901 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
ANDA | ANDA062752 |
COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
Color | C48331;C48330 __ |
FDA SPL set id | 406382 |
Imprint code | 5266 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2022-04-01 |
Marketing effective time low | 2016-12-19 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-01 |
NDC Item | 51991090701 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-05 |
NDC Item | 51991090705 |
Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
NDC 9 | 51991-907 |
---|---|
NDC 10 | 51991-907-33 |
NDC Item | 51991090733 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
ANDA | ANDA210662 |
COLORTEXT | BLUE |
Color | C48333 __ |
FDA SPL set id | 777555 |
Imprint code | B907 |
Labeler | Breckenridge Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-01-18 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-14 |
NDC Item | 52959033614 |
Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-20 |
NDC Item | 52959033620 |
Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-28 |
NDC Item | 52959033628 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-30 |
NDC Item | 52959033630 |
Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-40 |
NDC Item | 52959033640 |
Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-56 |
NDC Item | 52959033656 |
Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-03-23 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 22 mm |
Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
NDC 9 | 52959-336 |
---|---|
NDC 10 | 52959-336-90 |
NDC Item | 52959033690 |
Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
ANDA | ANDA060704 |
COLORTEXT | BLACK,YELLOW |
Color | C48323;C48330 __ |
FDA SPL set id | 75103 |
Imprint code | Z;2407 |
Labeler | H.J. Harkins Company, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Ma |